A detailed history of Brandes Investment Partners, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brandes Investment Partners, LP holds 1,378,205 shares of MRK stock, worth $133 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares
1,378,205
Previous 1,359,766 1.36%
Holding current value
$133 Million
Previous $168 Million 7.03%
% of portfolio
1.87%
Previous 2.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $2.05 Million - $2.38 Million
18,439 Added 1.36%
1,378,205 $157 Million
Q2 2024

Aug 19, 2024

BUY
$123.8 - $132.96 $15.8 Million - $16.9 Million
127,240 Added 10.32%
1,359,766 $168 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $11.7 Million - $13.6 Million
103,377 Added 9.16%
1,232,526 $163 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $14.1 Million - $15.3 Million
140,301 Added 14.19%
1,129,149 $123 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $5 Million - $5.55 Million
48,574 Added 5.17%
988,848 $102 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $628,526 - $685,065
-5,787 Reduced 0.61%
940,274 $108 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $7.04 Million - $7.85 Million
68,383 Added 7.79%
946,061 $101 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $27.8 Million - $35.6 Million
-317,550 Reduced 26.57%
877,678 $97.4 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $26.1 Million - $29.4 Million
-309,095 Reduced 20.55%
1,195,228 $103 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $1.69 Million - $1.91 Million
-20,183 Reduced 1.32%
1,504,323 $137 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $4.89 Million - $5.49 Million
66,575 Added 4.57%
1,524,506 $125 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $677,769 - $848,993
9,377 Added 0.65%
1,457,931 $112 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $3.23 Million - $3.55 Million
45,015 Added 3.21%
1,448,554 $109 Million
Q2 2021

Aug 11, 2021

BUY
$70.31 - $77.77 $28.3 Million - $31.3 Million
403,021 Added 40.28%
1,403,539 $109 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $12.6 Million - $14.9 Million
183,295 Added 22.43%
1,000,518 $77 Million
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $508,849 - $564,718
-7,090 Reduced 0.86%
817,223 $65.9 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $9.77 Million - $11.1 Million
-133,473 Reduced 13.94%
824,313 $68.4 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $9.91 Million - $11.3 Million
-140,703 Reduced 12.81%
957,786 $74.1 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $3.3 Million - $4.57 Million
-52,089 Reduced 4.53%
1,098,489 $84.5 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $3.68 Million - $4.16 Million
-47,491 Reduced 3.96%
1,150,578 $105 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $9.09 Million - $9.91 Million
-119,454 Reduced 9.07%
1,198,069 $101 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $5.22 Million - $6.1 Million
-74,715 Reduced 5.37%
1,317,523 $110 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $4.08 Million - $4.65 Million
-58,593 Reduced 4.04%
1,392,238 $116 Million
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $16.6 Million - $19.3 Million
-254,424 Reduced 14.92%
1,450,831 $111 Million
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $1.94 Million - $2.28 Million
-33,564 Reduced 1.93%
1,705,255 $121 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $1.49 Million - $1.75 Million
-29,333 Reduced 1.66%
1,738,819 $106 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $6.43 Million - $7.48 Million
126,236 Added 7.69%
1,768,152 $96.3 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $2.23 Million - $2.66 Million
43,130 Added 2.7%
1,641,916 $92.4 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $93.8 Million - $101 Million
1,598,786
1,598,786 $126 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Brandes Investment Partners, LP Portfolio

Follow Brandes Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.